Renal cortical mitochondrial aconitase is regulated in hypo- and hypercitraturia  by Melnick, Joel Z. et al.
Renal cortical mitochondrial aconitase is regulated in hypo- and
hypercitraturia
JOEL Z. MELNICK, PATRICIA A. PREISIG, ORSON W. MOE, PAUL SRERE, and ROBERT J. ALPERN
Department of Internal Medicine, University of Texas Southwestern Medical Center and Veterans Affairs Medical Center, Dallas, Texas,
and Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois, USA
Renal cortical mitochondrial aconitase is regulated in hypo- and hyper-
citraturia.
Background. Chronic metabolic acidosis and K1 deficiency increase,
while alkali feeding decreases proximal tubule citrate absorption and
metabolism. The present studies examined the regulation of mitochon-
drial aconitase (m-aconitase), the first step in mitochondrial citrate
metabolism, in these conditions.
Methods. Rats were fed appropriate diets, and m-aconitase activity and
protein abundance measured.
Results. In chronic metabolic acidosis and chronic K1 deficiency, renal
cortical m-aconitase activity was increased 17% and 43%, respectively.
This was associated with respective 90% and 221% increases in renal
cortical m-aconitase protein abundance. With chronic alkali feeding, there
was a 12% decrease in renal cortical m-aconitase activity, associated with
a 35% decrease in m-aconitase protein abundance. Hepatic m-aconitase
activity was not regulated in a similar manner. There was no regulation of
citrate synthase, the enzyme responsible for mitochondrial citrate synthe-
sis.
Conclusions. These studies demonstrate tissue specific chronic regula-
tion of renal cortical m-aconitase activity and protein abundance, which
likely contributes to the hypocitraturia and hypercitraturia seen in these
conditions. As m-aconitase is the only step in citrate transport and
metabolism found to be regulated in alkali feeding, its regulation likely
plays a significant role in mediating the hypercitraturia seen in this
condition.
Citrate is an important inhibitor of urinary stone forma-
tion [1]. Urinary citrate excretion is significantly lower in
patients with calcium nephrolithiasis than in normal sub-
jects [2–4]. Urinary citrate excretion is regulated by the rate
of proximal tubular citrate reabsorption. In the proximal
tubule, citrate is reabsorbed by an apical membrane Na/
citrate cotransporter encoded by a renal sodium/dicarboxy-
late cotransporter (NaDC-1) [5], and then is metabolized
by two potential pathways: (1) cytoplasmic metabolism via
adenosine triphosphate (ATP) citrate lyase [6]; or (2)
mitochondrial metabolism via the citric acid cycle [7]. Both
of these pathways eventually generate cytoplasmic oxalo-
acetate that can be metabolized via phosphoenolpyruvate
carboxykinase (PEPCK). Chronic metabolic acidosis and
chronic K1 depletion cause hypocitraturia, which is associ-
ated with adaptive increases in the activities of: (1) the
apical membrane Na/citrate cotransporter [8–10]; (2) ATP
citrate lyase [6]; and (3) PEPCK [11]. While alkali feeding
is associated with hypercitraturia, regulation of the above
pathways has not been found in this condition. In addition,
in spite of its proposed importance, chronic regulation of
mitochondrial pathways for citrate metabolism has not
been demonstrated.
Mitochondrial aconitase (m-aconitase) is an Fe21-con-
taining enzyme responsible for citrate metabolism to iso-
citrate. The reaction is as follows:
Citrateª @cis-aconitate 1 H2O#ª Isocitrate
Cis-aconitate never leaves the enzyme, and thus serves as
an intermediate. Inhibition of m-aconitase activity is re-
sponsible for high rates of citrate synthesis and high citrate
levels in the prostate [12]. In the present studies we
examined whether m-aconitase is chronically regulated in
renal cortical mitochondria. The results demonstrate that
chronic metabolic acidosis and chronic K1 deficiency in-
crease, while chronic alkali feeding decreases m-aconitase
activity.
METHODS
Animal protocols
Experiments were performed using male Sprague-Daw-
ley rats (200 to 230 g) treated as follows for seven days:
Chronic acid feeding. Animals were pair fed a basic diet
consisting of ground 4%-fat rat/mouse chow (Teklad Pre-
mier Laboratory Diets, Madison, WI, USA). Acid fed rats
received 0.28 M NH4Cl in tap water ad libitum, whereas
controls received regular tap water ad libitum. This proto-
col causes a mild metabolic acidosis (DHCO3
2 5 2.8
mEq/liter), no change in serum K1, and significant hypoci-
traturia [6].
Chronic alkali feeding. All animals received a synthetic
diet consisting of (in g): 180 casein, 200 cornstarch, 500
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sucrose, 35 corn oil, 35 peanut oil, 10 CaHPO4, 6 MgSO4,
6 NaCl, 8.3 K2HPO4, and 10 vitamin fortification mixture
(ICN Nutritional Biochemicals, Cleveland, OH, USA). For
control animals the diet was supplemented with NaCl, 6
mmol/kg body wt per day, while alkali fed rats received the
same diet supplemented with NaHCO3, 6 mmol/kg body wt
per day. This protocol does not alter acid/base parameters
or serum K1, but causes significant hypercitraturia [6].
Chronic K1 deficiency. Control animals received a diet of
(in g): 180 casein, 200 cornstarch, 500 sucrose, 35 corn oil,
35 peanut oil, 10 CaHPO4, 6 MgSO4, 6.8 Na2PO4, 7.1 KCl,
and 10 vitamin fortification mixture, while experimental
animals received a similar diet with NaCl substituted for
KCl. This protocol causes hypokalemia (DK1 5 1.1 mEq/
liter), no change in the blood HCO3
2 concentration, and
significant hypocitraturia [6].
Mitochondrial aconitase (m-aconitase) activity
m-Aconitase was assayed in mitochondrial suspensions
as the rate of generation of aconitate from isocitrate [13].
Following treatment, animals were anesthetized with
Inactin®, 100 mg/kg of body wt, and kidneys were excised
and placed in ice-cold phosphate buffered saline (PBS).
Cortex was dissected over an iced petri dish and mitochon-
dria were prepared by differential centrifugation as de-
scribed [14]. An aliquot of mitochondrial suspension was
then freeze-thawed 3 2 at 270° and centrifuged at
14,000 3 g for 30 minutes. Fifty microliters of supernatant
were added to the assay buffer to achieve a final volume of
1 ml (final composition: 100 mM Tris/HCl, pH 8.0, and 50
mM d, l-Na3Isocitrate). The reaction was followed for five
minutes, and aconitate was measured as absorbance at a
wavelength of 240 nm with an extinction coefficient of
3.6/mmole. Activity is reported as mmol aconitate formed
per min per mg mitochondrial protein (bicinchoninic acid
assay; Pierce, Rockford, IL, USA).
Citrate synthase activity
Citrate synthase was assayed in mitochondrial suspen-
sions as described [14]. Two microliters of resuspended,
disrupted (freeze-thaw) mitochondria were added to a
solution containing (in ml) 405 H2O, 15 acetyl CoA (10
mg/ml), and 50 5, 59-dithio-bis-[2-nitrobenzoic] acid
(DTNB) (0.67 mg/ml of 1 M Tris-HCl, pH 8.1). Baseline
CoA production was measured over two minutes as absor-
bance at 412 nm using an extinction coefficient of 13.6/
mmole. Oxaloacetate-dependent CoA production was mea-
sured by adding 25 ml of oxaloacetate (1.3 mg/ml of 1 M
Tris-Cl, pH 8.1) to the solution and following the reaction
for an additional four minutes. Citrate synthase activity was
determined by subtracting the slope of baseline CoA
production from oxaloacetate-dependent CoA production.
Western blot
The mitochondrial freeze-thaw supernatant was size
fractionated by SDS/PAGE on an 8% gel and electro-
phoretically transferred to nitrocellulose. After blocking
with 5% nonfat milk and 0.1% Tween-20 in TBS for one
hour, blots were probed in the same buffer for one hour
with a polyclonal anti-m-aconitase antibody directed
against purified pig liver m-aconitase, at a dilution of 1:200.
Blots were washed in TBS containing 0.1% Tween-20 for
15 minutes 3 3, and then in PBS for five minutes 3 1. Blots
were then incubated with a 1:5,000 dilution of peroxidase-
labeled sheep anti-rabbit IgG in TBS with 0.1% Tween-20
for one hour, washed as above, and then visualized by
enhanced chemiluminescence (Amersham). Protein abun-
dance was quantitated by densitometry.
Sigma Chemical Co. (St. Louis, MO, USA) supplied all
chemicals unless otherwise noted. Data are expressed as
mean 6 SEM. All comparisons were made using a paired
t-test.
RESULTS
m-Aconitase activity was measured on mitochondria
from renal cortical homogenates as the generation of
aconitate from isocitrate. Chronic metabolic acidosis
caused a 17% increase in m-aconitase activity (165 6 12 vs.
141 6 11 mmol aconitate/mg protein/min, N 5 14, P ,
0.02; Fig. 1). This was associated with a 90 6 19% increase
in m-aconitase protein abundance (N 5 9, P , 0.03; Fig. 2).
Chronic K1 deficiency also caused a 43% increase in
m-aconitase activity (63 6 4 vs. 44 6 5 mmol aconitate/mg
protein/min, N 5 7, P , 0.05; Fig. 3), which was associated
with a 221 6 103% increase in protein abundance (N 5 6,
Fig. 1. Renal cortical m-aconitase activity: Chronic metabolic acidosis.
Following treatment, renal cortical mitochondria were isolated and m-
aconitase activity measured. *P , 0.02.
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P , 0.01; Fig. 4). Thus, m-aconitase activity is increased in
acidosis and K1 deficiency, similar to the activities of a
number of proximal tubule enzymes.
In spite of the fact that chronic alkali feeding causes
profound hypercitraturia, it has been difficult to find a
regulated metabolic pathway in this condition. Chronic
alkali feeding caused an 18% decrease in m-aconitase
activity (99 6 18 vs. 121 6 21 mmol aconitate/mg protein/
min, N 5 7, P , 0.03; Fig. 5), which was associated with a
35 6 8% decrease in protein abundance (N 5 13, P , 0.02;
Fig. 6).
To examine the tissue specificity of these effects, m-
aconitase activity was measured in hepatic mitochondria.
By contrast to kidney, hepatic m-aconitase activity tended
to be inhibited in chronic metabolic acidosis and K1
deficiency (Fig. 7). In chronic metabolic acidosis, activity
was inhibited by 16% (21 6 2 vs. 25 6 1 mmol aconitate/mg
protein/min, N 5 15, P 5 0.076). In K1 deficiency, activity
was inhibited by 15% (11 6 2 vs. 13 6 2 mmol aconitate/mg
protein/min, N 5 6, P , 0.05). Chronic alkali feeding
caused no change in hepatic m-aconitase activity (26 6 4
[control] vs. 32 6 6 [alkali] mmol aconitate/mg protein/min,
N 5 11, NS), but once again the tendency was opposite in
direction to that of the kidney. Thus, regulation of m-
aconitase activity in these conditions is tissue specific.
Renal cortical citrate synthase activity was not regulated
in acidosis or alkalosis. Citrate synthase activity was 434 6
43 nmol CoA/mg protein/min in control and 471 6 30 nmol
CoA/mg protein/min in acidotic rats (NS). Citrate synthase
activity was 438 6 42 nmol CoA/mg protein/min in control
and 456 6 47 nmol CoA/mg protein/min in alkali fed rats
(NS).
DISCUSSION
The present results demonstrate that chronic metabolic
acidosis and chronic K1 deficiency lead to increases in the
activity of renal cortical m-aconitase, the first step in
mitochondrial citrate metabolism. This effect is tissue
specific in that it is not seen in liver, an observation similar
to that found with regulation of ATP citrate lyase and
PEPCK by acidosis [6, 15]. Increased activity was seen in
mitochondrial homogenates assayed under identical condi-
tions, indicating that the altered activity persists in the
absence of a persistent change in pH or K1 concentration.
Thus, the intrinsic properties of m-aconitase have been
altered, at least a part of which is due to an increase in the
abundance of the protein.
As metabolic acidosis and K1 deficiency both lead to
intracellular acidosis [16], but have opposite effects on
extracellular pH, the observation that they have similar
effects on m-aconitase activity and protein abundance
implies that intracellular pH is the key regulatory determi-
nant. This is similar to renal proximal tubule regulation of
glutaminase, PEPCK, ATP citrate lyase, the Na/citrate
cotransporter, the Na/H antiporter, and the Na/HCO3
cotransporter, which are all activated in chronic metabolic
acidosis and K1 deficiency [6, 9, 10, 17–20].
Chronic metabolic acidosis and K1 deficiency lead to
adaptive increases in the apical membrane Na/citrate co-
transporter encoded by NaDC-1 [9, 10], which would lead
to increases in tissue citrate levels. However, increased
citrate absorption in these conditions is associated with
Fig. 2. M-aconitase protein abundance:
chronic metabolic acidosis. Following treatment
of the animals, renal cortical mitochondria were
isolated and m-aconitase protein abundance
was measured by Western blot.
Fig. 3. Renal cortical m-aconitase activity: K1 deficiency. Following
treatment, renal cortical mitochondria were isolated and m-aconitase
activity measured. *P , 0.05.
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decreased tissue citrate levels [7], suggesting coexistent
regulation of citrate metabolism. Citrate can be metabo-
lized within the cytoplasm by ATP citrate lyase, which is
up-regulated in chronic metabolic acidosis and K1 defi-
ciency and contributes to the hypocitraturia seen in these
conditions [6]. The present studies show that mitochondrial
pathways of citrate metabolism are also up-regulated in
these conditions. Activation of m-aconitase along with
activation of glutaminase and glutamate dehydrogenase
(rate limiting enzymes in ammonia synthesis) in these
conditions leads to increased generation of a-ketogluta-
rate, which can then be metabolized to malate, and exit
mitochondria on the tricarboxylate exchanger. Cytoplasmic
malate is then metabolized by cytoplasmic malate dehy-
drogenase to oxaloacetate, which is also formed from
metabolism of citrate by cytoplasmic ATP citrate lyase.
Oxaloacetate is then metabolized by PEPCK to phos-
phoenolpyruvate, which eventually can be metabolized to
glucose or can reenter the citric acid cycle as acetyl CoA.
As noted above, PEPCK activity is also increased in chronic
metabolic acidosis and K1 deficiency [17].
While many steps of citrate transport and metabolism
are up-regulated in the above hypocitraturic conditions, it
has been difficult to demonstrate the site of regulation in
chronic alkali feeding, which is associated with significant
hypercitraturia. Neither Na/citrate cotransporter activity
nor ATP citrate lyase activity are inhibited by alkali feeding
[6, 9]. In prostate, high levels of citrate synthesis are due to
Fig. 4. M-aconitase protein abundance:
Chronic K1 deficiency. Following treatment of
the animals, renal cortical mitochondria were
isolated and m-aconitase protein abundance
was measured by Western blot.
Fig. 5. Renal cortical m-aconitase activity: Chronic alkali feeding. Fol-
lowing treatment, renal cortical mitochondria were isolated and m-
aconitase activity measured. *P , 0.03.
Fig. 6. M-aconitase protein abundance: Chronic alkali feeding. Follow-
ing treatment of the animals, renal cortical mitochondria were isolated
and m-aconitase protein abundance was measured by Western blot.
Fig. 7. Hepatic m-aconitase activity in chronic metabolic acidosis, K1
deficiency, and alkali feeding. Following treatment, hepatic mitochondria
were isolated and m-aconitase activity measured. *P , 0.05. Con, control;
K1 def, K1 deficiency.
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inhibition of m-aconitase activity [12]. We therefore rea-
soned that inhibition of m-aconitase could provide a mech-
anism for inhibition of proximal tubule citrate metabolism
in alkali feeding. Alkali feeding caused a decrease in
m-aconitase activity and protein abundance. Again, this
effect was tissue specific and was not seen in liver. In
prostate, inhibition of m-aconitase activity is due to high
zinc levels which inhibit the enzyme, rather than changes in
protein abundance, as in the kidney. In preliminary studies
using nuclear magnetic resonance spectroscopy, infusion of
13C-citrate into rats led to a 13C signal in glutamate (a
marker of the mitochondrial citric acid cycle), but not in
b-OH butyric acid (a marker of cytoplasmic metabolism)
(unpublished observations, J. Woods, S. Aruga, P.A.
Preisig, R.J. Alpern, C. Malloy). This suggests that under
baseline conditions, citrate is metabolized mostly by mito-
chondrial pathways; thus inhibition of this pathway would
be expected to lead to hypercitraturia.
A consistent observation in the present studies was that
the percent change in activity occurring in the various
conditions was always of smaller magnitude than the per-
cent change in protein abundance. This may be related to
posttranslational regulation of m-aconitase, as is seen in the
prostate [12]. This is similar to our findings with regulation
of ATP citrate lyase in chronic metabolic acidosis [6]. It can
also be seen that there was significant variability in the
control m-aconitase activities. This is likely due to the fact
that each of the control groups was fed a different diet. For
the acid studies, control rats received a Teklad diet, while
for the alkali and K1 deficiency studies different synthetic
diets were used. These diets varied in acid/alkali, Na1, and
K1 content, all of which significantly affect urinary citrate
excretion. In addition, the experimental diets were some-
times not completely eaten and control animals were
pair-fed. This is key in these studies, because starvation has
significant effects on citrate reabsorption and excretion
[21].
It is of significant interest that while m-aconitase is
regulated in acid-base disorders, citrate synthase is not.
Srere has proposed that the citric acid cycle enzymes exist
as a complex wherein one enzyme’s product is passed to the
next enzyme as substrate [22]. In support of this is the
observation that the enzymes of the citric acid cycle are
regulated coordinately in many conditions (all go up or
down together) [23]. However, in iron deficiency m-aconi-
tase is regulated in the absence of regulation of other citric
acid cycle enzymes [23]. This is likely due to the fact that
m-aconitase plays a role in iron metabolism while other
citric acid cycle enzymes do not [23]. A similar situation
may exist in acidosis and alkalosis. Changes in metabolism
of citrate transported into mitochondria require an altered
flux through m-aconitase, while there is no requirement for
an altered flux through citrate synthase. A similar situation
exists in prostate where enhanced synthesis of citrate is due
to selective inhibition of m-aconitase [12].
The present studies demonstrate that renal cortical m-
aconitase activity is up-regulated in chronic metabolic
acidosis and K1 deficiency, and down-regulated with
chronic alkali feeding. In the former hypocitraturic condi-
tions this represents an additional mechanism of stimula-
tion of citrate metabolism. With chronic alkali feeding, this
is the first demonstrated mechanism for chronic inhibition
of citrate metabolism. Changes in m-aconitase activity are
due, at least in part, to changes in m-aconitase protein
abundance.
ACKNOWLEDGMENTS
The authors gratefully acknowledge the technical assistance of Martha
Ferguson and Hsin-Yi Chang. These studies were supported by a grant
from the NIH P01-DK20543 (RJA) and the Veterans Administration
(OWM and PS). JZM was supported by NIH institutional training grant
T32-DK07659 and a grant from Northwestern University.
Reprint requests to Joel Melnick, M.D., Pediatrics W-140, Northwestern
University Medical School, 303 E. Chicago Ave., Chicago, IL 60611-3008
USA
E-mail: j-melnick@nwu.edu
REFERENCES
1. KISSIN B, LOCKS MO: Urinary citrates in calcium urolithiasis. Proc Soc
Exp Biol 46:216–218, 1941
2. NICAR MJ, SKURLA C, SAKHAEE K, PAK CYC: Low urinary citrate
excretion in nephrolithiasis. Urology 21:8–14, 1983
3. SCHWILLE PO, SCHOLZ D, SCHEILLW K, LEUTSCHAFT R, GOLDBERG I,
SIGEL A: Citrate in urine and serum and associated variables in
subgroups of urolithiasis. Nephron 31:194–202, 1982
4. HOSKING DH, WILSON JWL, LIEDKE RR, SMITH LH: Urinary citrate
excretin in normal persons and patients with idiopathic calcium
urolithiasis. J Lab Clin Med 106:682–689, 1985
5. PAJOR AM: Sequence and functional characterization of a renal
sodium/dicarboxylate cotransporter. J Biol Chem 270:5779–5785, 1995
6. MELNICK JZ, SRERE PA, ELSHOURBAGY NA, MOE OW, PREISIG PA,
ALPERN RJ: Adenosine triphosphate citrate lyase mediates hypocitra-
turia in rats. J Clin Invest 98:2381–2387, 1996
7. SIMPSON DP: Citrate excretion: A window on renal metabolism. Am J
Physiol 244:F223–F234, 1983
8. ARUGA S, PREISIG PA, MOE OW, PAJOR A, ALPERN RJ: Chronic
metabolic acidosis (CMA) increases renal cortical NaDC-1 mRNA
and protein abundance in rats. (abstract) J Am Soc Nephrol 8:2A, 1997
9. JENKINS AD, DOUSA TP, SMITH LH: Transport of citrate across renal
brush border membrane: Effects of dietary acid and alkali loading.
Am J Physiol 249:F590–F595, 1985
10. LEVI M, MCDONALD LA, PREISIG PA, ALPERN RJ: Chronic K
depletion stimulates rat renal brush-border membrane Na-citrate
cotransporter. Am J Physiol 261:F767–F773, 1991
11. HWANG JJ, CURTHOYS NP: Effect of acute aterations in acid-base
balance on rat renal glutaminase and phosphoenolpyruvate carboxyki-
nase gene expression. J Biol Chem 266:9392–9396, 1991
12. COSTELLO LC, FRANKLIN RB: Citrate metabolism of normal and
malignant prostate epithelial cells. Urology 50:3–12, 1997
13. KENNEDY MD, EMPTAGE MG, DREYER J, BEINERT H: The role of iron
in the activation-inactivation of aconitase. J Biol Chem 258:11098–
11105, 1983
14. DARLEY-USMAR VM, RICKWOOD D, WILSON MT: Mitochondria: A
Practical Approach. Washington, D.C., IRL Press, 1987
15. POLLOCK AS: Induction of renal phosphoenolpyruvate carboxykinase
Melnick et al: Mitochondrial aconitase and citrate metabolism164
mRNA: Suppressive effect of glucose. Am J Physiol 257:F145–F151,
1989
16. ADAM WR, KORETSKY AP, WEINER MW: 31P NMR in vivo measure-
ment of renal intracellular pH: Effects of acidosis and K depletion in
rats. Am J Physiol 251:F904–F910, 1986
17. TANNEN RL: Relationship of renal ammonia production and potas-
sium homeostasis. Kidney Int 11:453–465, 1977
18. AKIBA T, ROCCO VK, WARNOCK DG: Parallel adaptation of the rabbit
renal cortical sodium/proton antiporter and sodium/bicarbonate co-
transporter in metabolic acidosis and alkalosis. J Clin Invest 80:308–
315, 1987
19. PREISIG PA, ALPERN RJ: Chronic metabolic acidosis causes an
adaptation in the apical membrane Na/H antiporter and basolateral
membrane Na(HCO3)3 symporter in the rat proximal convoluted
tubule. J Clin Invest 82:1445–1453, 1988
20. SOLEIMANI M, BERGMAN JA, HOSFORD MA, MCKINNEY TD: Potas-
sium depletion increases luminal Na/H exchange and basolateral
Na:CO3:HCO3 cotransport in rat renal cortex. J Clin Invest 86:1076–
1083, 1990
21. WINDUS DW, COHN DE, HEIFETS M: Effects of fasting on citrate
transport by the brush-border membrane of rat kidney. Am J Physiol
251:F678–F682, 1986
22. SRERE PA: Complexes of sequential metabolic enzymes. Ann Rev
Biochem 56:89–124, 1987
23. SRERE PA: An exception that proves the rule. Trends Biochem Sci
22:11, 1997
Melnick et al: Mitochondrial aconitase and citrate metabolism 165
